Search clinical trials for: Risperidone Long-Acting injectable or oral antipsychotics

Total 836 results

Janssen, LP

Completed

Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia
Janssen-Ortho Inc., Canada

Completed

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

Bipolar Disorder
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

Bipolar Disorder | Manic Disorder
Stony Brook University

Completed

Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children

Agitation

United States
National Center for Research Resources (NCRR)
Yale University

Completed

Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome

Tourette Syndrome
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia
Bristol-Myers Squibb
Otsuka America Pharmaceutical

Terminated

A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome

Schizophrenia | Metabolic Syndrome

France, Hungary, Spain, Czech Republic, Belgium, Germany, Greece, Switzerland, Turkey
Centre for Addiction and Mental Health

Unknown

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Canada
New York State Psychiatric Institute
Columbia University; National Institute on Aging (NIA)

Completed

Antipsychotic Discontinuation in Alzheimer's Disease (ADAD)

Aggression | Psychotic Disorders | Alzheimer Disease | Agitation

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

Schizophrenia
Janssen Korea, Ltd., Korea

Completed

The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania

Bipolar Disorder
Capital Medical University

Completed

Risperidone Maintenance Treatment in Schizophrenia

Schizophrenia

China
University of South Florida
Janssen, LP

Completed

A Study of Risperidone Monotherapy in Bipolar Anxiety

Generalized Anxiety Disorder | Bipolar Disorder | Panic Disorder

United States
Braeburn Pharmaceuticals

Completed

Safety and Tolerability of Risperidone Implants

Schizophrenia

United States
Braeburn Pharmaceuticals

Completed

Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

Schizophrenia | Schizo-affective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.

Psychotic Disorders | Schizophrenia
Rovi Pharmaceuticals Laboratories

Recruiting

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse (RESHAPE)

Schizophrenia

Germany
Marion Trousselard

Terminated

Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?

Anxiety State

France
University of Geneva, Switzerland

Terminated

Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome

22q11.2 Deletion Syndrome

Switzerland
University of Alabama at Birmingham
Janssen Pharmaceuticals

Completed

Risperidone and Suicidality in Major Depressive Disorder

Depression

United States
Hoffmann-La Roche

Completed

A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone

Schizophrenia

United States
Child Psychopharmacology Institute

Completed

Actigraphic Analysis of Treatment Response

Psychomotor Agitation | Insomnia | Sleep Disorders, Circadian Rhythm

United States
Pfizer

Completed

Study Evaluating Vabicaserin in Subjects With Schizophrenia

Schizophrenia

United States, Canada
Pfizer

Completed

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

Psychotic Disorders | Schizophrenia

Russian Federation, Canada
Central South University
Shanghai Mental Health Center; Capital Medical University; Guangzhou Mental Hospital and other collaborators

Completed

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

Schizophrenia

China
GlaxoSmithKline

Completed

Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

Schizophrenia

United States
Duke University
Janssen, LP

Completed

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

Schizophrenia | Schizoaffective Disorder

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

Psychotic Disorders | Schizophrenia
Janssen, LP

Completed

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Schizophrenia | Schizoaffective Disorder
Central Institute of Mental Health, Mannheim

Completed

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Schizophrenia, Schizoaffective Disorder

Germany
Birte Glenthoj
Icahn School of Medicine at Mount Sinai

Terminated

The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia

Schizophrenia

Denmark
ValiSeek Limited

Completed

A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Adenocarcinoma | Carcinoma, Non-Small-Cell Lung
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia (PRISMA-2)

Schizophrenia

United States
Indivior Inc.

Completed

Single Ascending Dose Study of RBP-7000

Schizophrenia

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Psychotic Disorders | Schizophrenia | Emergency Treatment
University of California, Irvine

Active, not recruiting

Adaptive Interventions for Optimizing Malaria Control: A Cluster-Randomized SMART Trial

LLIN, PBO LLIN, IRS, Larviciding

United States, Kenya
Vanguard Research Group
Otsuka America Pharmaceutical

Completed

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics (PRELAPSE)

Schizophrenia

United States
Cliniques universitaires Saint-Luc- Université...

Completed

β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS (SANAT)

Schizophrenia

Belgium
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone

Schizophrenia

United States
Indivior Inc.

Completed

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia

Psychotic Disorders | Schizophrenia

United States
Janssen-Cilag Ltd.

Completed

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Schizophrenia

Brazil
Northwell Health
National Institutes of Health (NIH)

Completed

Striatal Connectivity and Clinical Outcome in Psychosis

Psychotic Disorders

United States
Si Tianmei

Unknown

A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

Sexual Dysfunction | Hyperprolactinemia

China
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Stichting...

Recruiting

Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT (SPACe2:STAR)

Autism Spectrum Disorder

Netherlands
Institut de Recherches Cliniques de Montreal
Novo Nordisk A/S; McMaster University

Completed

Levemir-Body Composition and Energy Metabolism

Type 2 Diabetes

Canada
Indivior Inc.

Completed

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders

Bipolar Disorder
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

Schizophrenia | Psychotic Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

Bipolar Disorders | Manic Disorder

3

Subscribe